Increased expression of TGF-β protein in the lesional skins of melasma patients following treatment with platelet-rich plasma
Autor: | Alaa Ghazally, Amira A Abdel-Motaleb, Mahmoud R. Hussein, Eman R. M. Hofny, Asmaa M. Ahmed |
---|---|
Rok vydání: | 2019 |
Předmět: |
Adult
Male Pathology medicine.medical_specialty Melasma Dermatology Melanosis 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Melanocyte differentiation Transforming Growth Factor beta medicine Humans Platelet Skin integumentary system Epidermis (botany) Platelet-Rich Plasma business.industry Arrector pili muscle medicine.disease medicine.anatomical_structure 030220 oncology & carcinogenesis Skin hyperpigmentation Platelet-rich plasma Female Surgery business Transforming growth factor |
Zdroj: | Journal of Cosmetic and Laser Therapy. 21:382-389 |
ISSN: | 1476-4180 1476-4172 |
DOI: | 10.1080/14764172.2019.1668016 |
Popis: | Background: Melasma is a common acquired facial hyperpigmented skin disorder. Platelet-rich plasma (PRP) is autologous plasma containing higher than normal platelets concentrations. Recently, PRP has been used as a therapeutic modality in melasma with significant clinical improvement, possibly due to its abundant contents of growth factors such as TGF-β. The latter represents a natural multifunctional polypeptide that negatively regulates melanocyte differentiation and therefore reduces skin hyperpigmentation. To date, the expression pattern of TGF-β protein in skin of melasma patients following PRP injection is unknown. Here we hypothesize that "injection of PRP in the lesional skin of melasma patients is associated with alterations of TGF-β protein expression".Patients and Methods: The study included 20 adult patients with melasma. Autologous PRP was delivered into the lesional skin either through microneedling or as intradermal microinjections. TGF-β protein expression was immunohistochemically examined in the perilesional and lesional skins before and after PRP treatment and in the healthy skins of nine volunteers (control group).Results: TGF-β protein was expressed within the epidermis, dermal adnexal structures, vascular endothelium, nerves and arrector pili muscle fibers of the healthy skins (control group), perilesional and lesional skins of melasma patients before and after treatment with PRP. Before treatment with PRP, the expression ofTGF-β protein in the lesional (1.26 ± 0.41) and perilesional (1.68 ± 0.51) skins of melasma patients were significantly lower than that in the healthy skins (2.26 ± 0.37, p value |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |